Explore by state
Select a state to see its bills, or view federal legislation below.
All legislation
463 billsBills in progress
135 still movingThese are not settled. This is where your voice can still change the outcome.
Already on the books
These bills are settled. Study them to see what to push for and what to guard against as similar bills move in your state.
Open comment periods
Have your say with federal health agencies
CMS, FDA, NIH, and other health agencies ask the public for input before they finalize rules and policies. Agency staff read every comment, and comments from patients and caregivers carry real weight. Each one below is open now. Anyone can comment, and you do not need a lawyer.
How to write a comment that counts
- Say who you are: a patient, caregiver, or advocate, and the condition you live with or work on.
- Tell one short, true story about how the issue affects your care, cost, or access.
- Say clearly what you want the agency to do or change.
- Submit before the closing date. Late comments may not be considered.
- Comments are public. Leave out health details you want to keep private.
Featured for patients
- CMSProposed ruleCloses Nov 23, 2026
Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards
This request for information (RFI) solicits input from interested parties for purposes of establishing standards for reasonable and relevant pharmacy contract terms and conditions under the Medicare prescription drug benefit. Section 6223(a) of the Consolidated Appropriations Act, 2026 (CAA, 2026) amends section 1860D- 4(b)(1)(A) of the Social Security Act (the Act) to require Part D plan sponsors to permit any pharmacy that meets standard contract terms and conditions under the plan to participate as a network pharmacy of the plan. Section 6223(a) of the CAA, 2026 further requires that, notwithstanding any other provision of law, for plan years beginning January 1, 2029, such standard contract terms and conditions offered by Part D plan sponsors must be reasonable and relevant according to standards established by the Secretary of the Department of Health and Human Services. Finally, section 6223(a) of the CAA, 2026 requires the Secretary to issue this RFI for purposes of establishing such standards.
All open health comment periods (17)
- FDANoticeCloses Nov 20, 2026
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
Submit a comment on Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information (opens in a new tab)Read the notice for Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information (opens in a new tab) - CMSProposed ruleCloses Nov 23, 2026
Request for Information; Medicare Part D Reasonable and Relevant Pharmacy Contracting Standards
- HHSProposed ruleCloses Nov 27, 2026
Patient Protection and Affordable Care Act, Exchange Pre-Eligibility Verification
- ACFProposed ruleCloses Nov 30, 2026
Reducing Bureaucracy and Burden for Block Grants
- FDANoticeCloses Dec 6, 2026
Challenges and Solutions in Lot-Level Food Traceability; Public Meeting
- CMSProposed ruleCloses Dec 7, 2026
Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes
Submit a comment on Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes (opens in a new tab)Read the notice for Clinical Laboratory Improvement Amendments of 1988 (CLIA); Virtual Access, Gynecologic Cytology Proficiency Testing (PT), Personnel Qualifications, and Other Changes (opens in a new tab) - FDANoticeCloses Dec 11, 2026
Fit-for-Purpose Rare Disease Framework Initiative; Public Meeting; Request for Information and Comments
- CMSProposed ruleCloses Dec 15, 2026
Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026
Submit a comment on Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026 (opens in a new tab)Read the notice for Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026 (opens in a new tab) - HHSProposed ruleCloses Dec 28, 2026
Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Urine (UrMG)
- HHSProposed ruleCloses Dec 28, 2026
Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Oral Fluid (OFMG)
- FDANoticeCloses Dec 31, 2026
FDA Rare Disease Innovation Hub Future Programming; Request for Comments
- FDANoticeCloses Jan 11, 2027
Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information
Submit a comment on Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information (opens in a new tab)Read the notice for Patient-Level Data for Drugs and Biological Products Submissions Containing Real-World Data and Real-World Evidence; Request for Information (opens in a new tab) - CMSProposed ruleCloses Jan 11, 2027
Medicare and Medicaid Programs; Cutting Administrative Requirements for Excellence in Patient Care
- CDCNoticeCloses Jan 15, 2027
Target Product Profile for a Human West Nile Virus Vaccine: Request for Information
- CDCNoticeCloses Jan 15, 2027
Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Prevention: Request for Information
- CDCNoticeCloses Jan 15, 2027
Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease: Request for Information
- FDAProposed ruleCloses Mar 2, 2027
Infant Formula Nutrient Requirements
Listed from the Federal Register and updated daily. We filter out paperwork and industry-only notices. Listing a comment period does not mean the Foundation supports or opposes the proposal.
The EMPWRD Patient Foundation
The Foundation, a South Carolina nonprofit, compiles and maintains this record. The tracker is updated daily.
Questions or corrections? Write to hello@empwrdpatientfoundation.org.
